Filed: May 08, 2018
Latest Update: May 08, 2018
Summary: ORDER PAUL S. DIAMOND , District Judge . AND NOW , this 8th day of May, 2018, upon consideration of Defendants Sanofi-Aventis U.S. LLC, GlaxoSmithKline LLC, GlaxoSmithKline Holdings (Americas) Inc., and Gr nenthal GmbH's Motion to Reallocate Special Master Fees and Costs Relating to Hagen Berman Sobol Shapiro LLC's Motions to Withdraw as Counsel (Doc. No. 615), Hagens Berman Sobol Shapiro LLP's Response (Doc. No. 617), Defendants' Reply (Doc. No. 623), and all related submissions, it is he
Summary: ORDER PAUL S. DIAMOND , District Judge . AND NOW , this 8th day of May, 2018, upon consideration of Defendants Sanofi-Aventis U.S. LLC, GlaxoSmithKline LLC, GlaxoSmithKline Holdings (Americas) Inc., and Gr nenthal GmbH's Motion to Reallocate Special Master Fees and Costs Relating to Hagen Berman Sobol Shapiro LLC's Motions to Withdraw as Counsel (Doc. No. 615), Hagens Berman Sobol Shapiro LLP's Response (Doc. No. 617), Defendants' Reply (Doc. No. 623), and all related submissions, it is her..
More
ORDER
PAUL S. DIAMOND, District Judge.
AND NOW, this 8th day of May, 2018, upon consideration of Defendants Sanofi-Aventis U.S. LLC, GlaxoSmithKline LLC, GlaxoSmithKline Holdings (Americas) Inc., and Grünenthal GmbH's Motion to Reallocate Special Master Fees and Costs Relating to Hagen Berman Sobol Shapiro LLC's Motions to Withdraw as Counsel (Doc. No. 615), Hagens Berman Sobol Shapiro LLP's Response (Doc. No. 617), Defendants' Reply (Doc. No. 623), and all related submissions, it is hereby ORDERED that Defendants' Motion (Doc. No. 615) is DENIED without prejudice.
IT IS SO ORDERED.
